These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 37034173)
1. Probiotic supplement as a promising strategy in early tau pathology prevention: Focusing on GSK-3β? Flynn CM; Yuan Q Front Neurosci; 2023; 17():1159314. PubMed ID: 37034173 [TBL] [Abstract][Full Text] [Related]
2. Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration. Leroy K; Yilmaz Z; Brion JP Neuropathol Appl Neurobiol; 2007 Feb; 33(1):43-55. PubMed ID: 17239007 [TBL] [Abstract][Full Text] [Related]
3. Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link. Zhang Y; Huang NQ; Yan F; Jin H; Zhou SY; Shi JS; Jin F Behav Brain Res; 2018 Feb; 339():57-65. PubMed ID: 29158110 [TBL] [Abstract][Full Text] [Related]
4. Truncation and activation of GSK-3β by calpain I: a molecular mechanism links to tau hyperphosphorylation in Alzheimer's disease. Jin N; Yin X; Yu D; Cao M; Gong CX; Iqbal K; Ding F; Gu X; Liu F Sci Rep; 2015 Feb; 5():8187. PubMed ID: 25641096 [TBL] [Abstract][Full Text] [Related]
5. Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert. Engel T; Goñi-Oliver P; Lucas JJ; Avila J; Hernández F J Neurochem; 2006 Dec; 99(6):1445-55. PubMed ID: 17059563 [TBL] [Abstract][Full Text] [Related]
6. Anesthesia and tau pathology. Whittington RA; Bretteville A; Dickler MF; Planel E Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():147-55. PubMed ID: 23535147 [TBL] [Abstract][Full Text] [Related]
7. An experimental model of Braak's pretangle proposal for the origin of Alzheimer's disease: the role of locus coeruleus in early symptom development. Ghosh A; Torraville SE; Mukherjee B; Walling SG; Martin GM; Harley CW; Yuan Q Alzheimers Res Ther; 2019 Jul; 11(1):59. PubMed ID: 31266535 [TBL] [Abstract][Full Text] [Related]
8. GSK-3β and its Inhibitors in Alzheimer's Disease: A Recent Update. Chauhan N; Paliwal S; Jain S; Verma K; Paliwal S; Sharma S Mini Rev Med Chem; 2022; 22(22):2881-2895. PubMed ID: 35450523 [TBL] [Abstract][Full Text] [Related]
9. GSK-3 is essential in the pathogenesis of Alzheimer's disease. Takashima A J Alzheimers Dis; 2006; 9(3 Suppl):309-17. PubMed ID: 16914869 [TBL] [Abstract][Full Text] [Related]
10. ER stress is involved in Abeta-induced GSK-3beta activation and tau phosphorylation. Resende R; Ferreiro E; Pereira C; Oliveira CR J Neurosci Res; 2008 Jul; 86(9):2091-9. PubMed ID: 18335524 [TBL] [Abstract][Full Text] [Related]
11. Nano-Honokiol ameliorates the cognitive deficits in TgCRND8 mice of Alzheimer's disease via inhibiting neuropathology and modulating gut microbiota. Qu C; Li QP; Su ZR; Ip SP; Yuan QJ; Xie YL; Xu QQ; Yang W; Huang YF; Xian YF; Lin ZX J Adv Res; 2022 Jan; 35():231-243. PubMed ID: 35024199 [TBL] [Abstract][Full Text] [Related]
12. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Ferrer I; Barrachina M; Puig B Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379 [TBL] [Abstract][Full Text] [Related]
13. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease. Leroy K; Boutajangout A; Authelet M; Woodgett JR; Anderton BH; Brion JP Acta Neuropathol; 2002 Feb; 103(2):91-9. PubMed ID: 11810173 [TBL] [Abstract][Full Text] [Related]
14. The Link Between Diabetes Mellitus and Tau Hyperphosphorylation: Implications for Risk of Alzheimer's Disease. Hobday AL; Parmar MS Cureus; 2021 Sep; 13(9):e18362. PubMed ID: 34725612 [TBL] [Abstract][Full Text] [Related]
15. A novel GSK-3beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo. Serenó L; Coma M; Rodríguez M; Sánchez-Ferrer P; Sánchez MB; Gich I; Agulló JM; Pérez M; Avila J; Guardia-Laguarta C; Clarimón J; Lleó A; Gómez-Isla T Neurobiol Dis; 2009 Sep; 35(3):359-67. PubMed ID: 19523516 [TBL] [Abstract][Full Text] [Related]
16. Down-regulation of WW domain-containing oxidoreductase induces Tau phosphorylation in vitro. A potential role in Alzheimer's disease. Sze CI; Su M; Pugazhenthi S; Jambal P; Hsu LJ; Heath J; Schultz L; Chang NS J Biol Chem; 2004 Jul; 279(29):30498-506. PubMed ID: 15126504 [TBL] [Abstract][Full Text] [Related]
17. 17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner. Shi HR; Zhu LQ; Wang SH; Liu XA; Tian Q; Zhang Q; Wang Q; Wang JZ J Neural Transm (Vienna); 2008 Jun; 115(6):879-88. PubMed ID: 18217188 [TBL] [Abstract][Full Text] [Related]
18. SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3β activity in SH-SY5Y cells. Wu X; Kosaraju J; Tam KY Eur J Pharm Sci; 2017 Dec; 110():101-108. PubMed ID: 28359686 [TBL] [Abstract][Full Text] [Related]
19. Song X; Zhao Z; Zhao Y; Wang Z; Wang C; Yang G; Li S Nutr Neurosci; 2022 Dec; 25(12):2588-2600. PubMed ID: 34755592 [TBL] [Abstract][Full Text] [Related]
20. Isoorientin, a GSK-3β inhibitor, rescues synaptic dysfunction, spatial memory deficits and attenuates pathological progression in APP/PS1 model mice. Tan X; Liang Z; Li Y; Zhi Y; Yi L; Bai S; Forest KH; Nichols RA; Dong Y; Li QX Behav Brain Res; 2021 Feb; 398():112968. PubMed ID: 33069740 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]